Atea Pharmaceuticals annual depreciation and amortization
2018
2019
2020
2021
2022
2023
2024
2025
Atea Pharmaceuticals Depreciation & Amortization Growth & History (AVIR)
Atea Pharmaceuticals's depreciation and amortization was $416,000 for fiscal 2025.
View full Atea Pharmaceuticals company overviewAtea Pharmaceuticals annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $416,000 | $0 | 0.00% |
| 2024 | 2024-12-31 | $416,000 | $0 | 0.00% |
| 2023 | 2023-12-31 | $416,000 | $156,000 | +60.00% |
| 2022 | 2022-12-31 | $260,000 | $231,000 | +796.55% |
| 2021 | 2021-12-31 | $29,000 | $10,000 | +52.63% |
| 2020 | 2020-12-31 | $19,000 | $2,000 | +11.76% |
| 2019 | 2019-12-31 | $17,000 | $0 | 0.00% |
| 2018 | 2018-12-31 | $17,000 | — | — |
Atea Pharmaceuticals quarterly depreciation and amortization
Q3.19
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $104,000 | $0 | 0.00% |
| Q1 2026 | 2026-03-31 | $104,000 | $0 | 0.00% |
| Q4 2025 | 2025-12-31 | $104,000 | — | — |
| Q3 2025 | 2025-09-30 | $104,000 | $0 | 0.00% |
| Q2 2025 | 2025-06-30 | $104,000 | $0 | 0.00% |
| Q1 2025 | 2025-03-31 | $104,000 | $0 | 0.00% |
| Q3 2024 | 2024-09-30 | $104,000 | $0 | 0.00% |
| Q2 2024 | 2024-06-30 | $104,000 | $0 | 0.00% |
| Q1 2024 | 2024-03-31 | $104,000 | $0 | 0.00% |
| Q3 2023 | 2023-09-30 | $104,000 | −$2,000 | −1.89% |
| Q2 2023 | 2023-06-30 | $104,000 | $61,000 | +141.86% |
| Q1 2023 | 2023-03-31 | $104,000 | $97,000 | +1385.71% |
| Q3 2022 | 2022-09-30 | $106,000 | $99,000 | +1414.29% |
| Q2 2022 | 2022-06-30 | $43,000 | $35,000 | +437.50% |
| Q1 2022 | 2022-03-31 | $7,000 | $0 | 0.00% |
| Q3 2021 | 2021-09-30 | $7,000 | $2,000 | +40.00% |
| Q2 2021 | 2021-06-30 | $8,000 | $4,000 | +100.00% |
| Q1 2021 | 2021-03-31 | $7,000 | $3,000 | +75.00% |
| Q3 2020 | 2020-09-30 | $5,000 | $1,000 | +25.00% |
| Q2 2020 | 2020-06-30 | $4,000 | — | — |
| Q1 2020 | 2020-03-31 | $4,000 | — | — |
| Q3 2019 | 2019-09-30 | $4,000 | — | — |
Atea Pharmaceuticals depreciation and amortization trends
Over the last five fiscal years, Atea Pharmaceuticals's depreciation and amortization increased from $19,000 to $416,000, a change of $397,000. The latest reported quarter, Q2 2026, shows $104,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Atea Pharmaceuticals source filings ↗